This is a must read if you have invested in Amgen over the years. AMBS is on the launch pad and will up list in the near future.

http://ir.amarantus.com/company-news/detail/2...sory-board

MANF is proving itself around the world with scientists and researchers. There are many orphan indications coming up fast for AMBS and this could really be the best time to grab a tiger by the tail. The rest of the AMBS pipeline is also just as amazing.